QQ客服 官方微博 反馈留言

	AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations
	Bi, Jianling; Meng, Xiangbing; Li, Yujun; Yang, Shujie; Zhang, Yuping; Li, Mary; Liu, Haitao; Li, Yiyang; Mcdonald, Megan E.; Thiel, Kristina W.
刊名	CANCERS
	2018
卷号	10期号:5
关键词	p53 WEE1 PARP1 AZD1775 olaparib gemcitabine
ISSN号	2072-6694
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3538119
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Bi, Jianling,Meng, Xiangbing,Li, Yujun,et al. AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations[J]. CANCERS,2018,10(5).
APA	Bi, Jianling.,Meng, Xiangbing.,Li, Yujun.,Yang, Shujie.,Zhang, Yuping.,...&Leslie, Kimberly K..(2018).AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations.CANCERS,10(5).
MLA	Bi, Jianling,et al."AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations".CANCERS 10.5(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。